Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has launched Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg, an over-the-counter (OTC) therapeutic equivalent generic version of Nexium 24HR Capsules in the United States market as approved by the US Food and Drug Administration (USFDA).

Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg, is an OTC proton pump inhibitor used to treat frequent heartburn occurring two or more days a week in adults.

The combined market of Nexium 24HR Capsules and private label OTC Esomeprazole Magnesium products had US sales of around $311 million for the most recent twelve months ending in May 2018 according to IRI.

Dr. Reddy's Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg is available in 14 count bottles sold in cartons of 1, 2, or 3 bottles each. Each bottle contains a complete 14-day course of treatment.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.